Skip to content

Comparison of Spirulina Gels for Treating Stage II Grade B Periodontitis

Comparative Study Between Spirulina Gel and Spirulina Nanoparticles Gel for Treatment of Stage II Grade B Periodontitis: Randomized Control Clinical Study with Radiological and Biochemical Assessment

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06699654
Enrollment
15
Registered
2024-11-21
Start date
2024-10-21
Completion date
2025-05-01
Last updated
2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis Stage II

Brief summary

This randomized controlled clinical study investigates the effectiveness of Spirulina gel and Spirulina nanoparticles gel in treating Stage II Grade B periodontitis. The research aims to compare the two formulations in terms of clinical, radiological, and biochemical outcomes, such as pocket depth reduction, alveolar bone density improvement, and inflammatory marker levels. The study seeks to provide insights into the potential of Spirulina-based therapies for enhancing periodontal health.

Interventions

OTHERPlacebo gel

A gel without active Spirulina components applied as a control intervention.

DIETARY_SUPPLEMENTSpirulina Gel

A conventional Spirulina gel formulation applied as a periodontal therapy.

DIETARY_SUPPLEMENTSpirulina Nanoparticles Gel

A novel Spirulina nanoparticles gel formulation applied as a periodontal therapy.

Sponsors

Kafrelsheikh University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Intervention model description

Participants are randomly assigned to one of three arms: Spirulina Gel, Spirulina Nanoparticles Gel, or control. The interventions are administered over a defined period with radiological and biochemical assessments conducted at baseline and post-treatment.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with good systemic health. * Patients who can maintain good oral hygiene. * Attachment loss 3-4 mm and probing pocket depth ≤ 5mm.

Exclusion criteria

for this study include: · * Any systemic disease that affects the periodontium. · * Pregnant, postmenopausal women. · * People who take anti-inflammatory drugs, antibiotics, or vitamins within the previous 3 month. * People who use mouth washes regularly · * Participation in other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
Reduction in Probing Pocket Depth (PPD)at baseline, 1 month , 3 months, 6 monthsThe mean reduction in probing pocket depth in millimeters (mm) at periodontal sites treated with Spirulina gel and Spirulina nanoparticles gel.

Secondary

MeasureTime frameDescription
Radiographic Bone Density Improvementat baseline and after 6 monthsChanges in alveolar bone density measured using radiographic imaging techniques.
Biochemical Marker LevelsMeasured at baseline, 1 month ,3 months, and 6 monthsReduction in inflammatory markers specifically Superoxide dismutase enzyme levels in gingival crevicular fluid.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026